FDA: Anonymity Assured In Pending Cosmetic Manufacturing Practices Survey

 
• By Ryan Nelson

The agency clarified in an email to Rose Sheet that an independent contractor would be tasked with conducting a planned survey on current cosmetic manufacturing practices, which remains subject to public comment and OMB approval. Respondents could count on their responses to be anonymous, FDA says.

Businessman covering his face using a white paper with drawn question mark, like a mask, for hiding his identity. Isolated gray wall background.

More from Regulation

More from Policy & Regulation